glioblastomasbrain metastases of the breast cancermeningiomas without peritumoral edemaperitumoral area of the tumorVEGF-AVEGF-R1VEGF-CVEGF-R3IFR-1IFR-2TGF-β1глиобластомыметастазы рака молочной железы в головной мозгменингиомы без перитуморального отекаперитуморальная зона опухолиVEGF-АVEGF-R1VEGF-СVEGF-R3IFR-1IFR-2TGF-β11.1. Карахан В.Б., Семенова Ж.Б., Брюховецкий А.С. и др. Проблемы диагностики и хирургии метастатических опухолей мозга. Вестник Московского онкологического общества 2004;1:3–4. [Karahan V.B., Semenova J.B., Bryukhovetsky A.S. et al. Problems of diagnosis and surgery of metastatic brain tumors. Vestnik moskovskogo onkologicheskogo obshchestva = Bulletin of Moscow Cancer Society 2004;(1):3–4. (In Russ.)].Карахан В.Б., Семенова Ж.Б., Брюховецкий А.С. и др. Проблемы диагностики и хирургии метастатических опухолей мозга. Вестник Московского онкологического общества 2004;1:3–4. [Karahan V.B., Semenova J.B., Bryukhovetsky A.S. et al. Problems of diagnosis and surgery of metastatic brain tumors. Vestnik moskovskogo onkologicheskogo obshchestva = Bulletin of Moscow Cancer Society 2004;(1):3–4. (In Russ.)].2.2. Nassehi D. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Dan Med J 2013;60(4):B4626.Nassehi D. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Dan Med J 2013;60(4):B4626.3.3. Мартынов Б.В., Гайдар Б.В., ЩиголевЮ.С., Труфанов Г.Е. Метастатические опухоли головного мозга. Практическая нейрохирургия (руководство для врачей). СПб., 2002. С. 476–448 (а). [Martynov B.V., Gaidar B.V., Shchigolev Yu.S., Trufanov G.E. Brain metastatic tumors. Practical Neurosurgery (Guideline for Physicians). SPb., 2002. Pp. 476–485. (In Russ.)].Мартынов Б.В., Гайдар Б.В., ЩиголевЮ.С., Труфанов Г.Е. Метастатические опухоли головного мозга. Практическая нейрохирургия (руководство для врачей). СПб., 2002. С. 476–448 (а). [Martynov B.V., Gaidar B.V., Shchigolev Yu.S., Trufanov G.E. Brain metastatic tumors. Practical Neurosurgery (Guideline for Physicians). SPb., 2002. Pp. 476–485. (In Russ.)].4.4. Мацко Д.Е. Патологическая анатомия важнейших хирургических заболеваний нервной системы. Практическая нейрохирургия (руководство для врачей). СПб., 2002. С. 613–635. [Matsko D.E. Pathological anatomy of the most important surgical diseases of the nervous system. Practical Neurosurgery (Guideline for Physicians). SPb., 2002. Pp. 613–635. (In Russ.)].Мацко Д.Е. Патологическая анатомия важнейших хирургических заболеваний нервной системы. Практическая нейрохирургия (руководство для врачей). СПб., 2002. С. 613–635. [Matsko D.E. Pathological anatomy of the most important surgical diseases of the nervous system. Practical Neurosurgery (Guideline for Physicians). SPb., 2002. Pp. 613–635. (In Russ.)].5.5. Gacche R.N., Meshram R.J. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Prog Biophys Mol Biol 2013;113(2):333–54.Gacche R.N., Meshram R.J. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Prog Biophys Mol Biol 2013;113(2):333–54.6.6. Nijaguna M.B., Patil V., Urbach S. et al. Glioblastoma-derived Macrophage Colonystimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis. J Biol Chem 2015;290(38):23401–15.Nijaguna M.B., Patil V., Urbach S. et al. Glioblastoma-derived Macrophage Colonystimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis. J Biol Chem 2015;290(38):23401–15.7.7. Gacche R.N., Meshram R.J. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. Biochim Biophys Acta 2014;1846(1):161–79.Gacche R.N., Meshram R.J. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. Biochim Biophys Acta 2014;1846(1):161–79.8.8. Welti J., Loges S., Dimmeler S., Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest 2013, Aug;123(8):3190–200.Welti J., Loges S., Dimmeler S., Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest 2013, Aug;123(8):3190–200.9.9. Hashimoto I., Kodama J., Seki N. et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 2001;85:93–7.Hashimoto I., Kodama J., Seki N. et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 2001;85:93–7.10.10. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002;1:219–27.Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002;1:219–27.11.11. Nordqvist A.C., Mathiesen T. Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 2002;57(1):19–26.Nordqvist A.C., Mathiesen T. Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 2002;57(1):19–26.12.12. Березина В.В., Кравец Л.Я., Воловик М.Г., Шелудяков А.Ю. Реакция локального кровотока перитуморальной зоны супратенториальных опухолей на частичную декомпрессию мозга (вскрытие твердой моз- говой оболочки). Физиология человека 2008;4:45–6. [Berezina V.V., Kravets L.Ya., Volovik M.G., Sheludyakov A.Yu. Reaction of local blood flow in the peritumoral area of supratentorial tumors on partial brain decompression (opening of dura mater). Fiziologiya cheloveka = Human Physiology 2008; (4): 45–6. (In Russ.)].Березина В.В., Кравец Л.Я., Воловик М.Г., Шелудяков А.Ю. Реакция локального кровотока перитуморальной зоны супратенториальных опухолей на частичную декомпрессию мозга (вскрытие твердой моз- говой оболочки). Физиология человека 2008;4:45–6. [Berezina V.V., Kravets L.Ya., Volovik M.G., Sheludyakov A.Yu. Reaction of local blood flow in the peritumoral area of supratentorial tumors on partial brain decompression (opening of dura mater). Fiziologiya cheloveka = Human Physiology 2008; (4): 45–6. (In Russ.)].13.13. Nana A.W., Yang P.M., Lin H.Y. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression. Asian Pac J Cancer Prev 2015;16(16):6813–23.Nana A.W., Yang P.M., Lin H.Y. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression. Asian Pac J Cancer Prev 2015;16(16):6813–23.14.14. Hatva E., Kaipainen A., Mentula P. et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995;146(2):368–78.Hatva E., Kaipainen A., Mentula P. et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995;146(2):368–78.15.15. Miletic H. et al. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opin 2009;13(4):455–68.Miletic H. et al. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opin 2009;13(4):455–68.16.16. Lee S.H., Lee Y.S., Hong Y.G., Kang C.S. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. APMIS 2014;122(1):16–24.Lee S.H., Lee Y.S., Hong Y.G., Kang C.S. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. APMIS 2014;122(1):16–24.17.17. Jensen R., Lee J. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 2012;71(1):146–56.Jensen R., Lee J. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 2012;71(1):146–56.18.18. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and itsreceptors. Natгure Med 2003;9(6):669–76.Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and itsreceptors. Natгure Med 2003;9(6):669–76.19.19. Almeida L.O., Custódio A.C., Santos M.J. et al. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival. Cancer Genet Cytogenet 2010;198(1):15–21.Almeida L.O., Custódio A.C., Santos M.J. et al. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival. Cancer Genet Cytogenet 2010;198(1):15–21.20.20. Bhuiyan M.I., Kim J.C., Hwang S.N. et al. Ischemic tolerance associated with VEGF-C and VEGFR-3 signaling in the hippocampus of mice. Neuroscience 2015;290:90–102.Bhuiyan M.I., Kim J.C., Hwang S.N. et al. Ischemic tolerance associated with VEGF-C and VEGFR-3 signaling in the hippocampus of mice. Neuroscience 2015;290:90–102.21.21. Shin Y.J., Riew T.R., Park J.H., Lee M.Y. Expression of Vascular Endothelial Growth Factor-C (VEGF-C) and its receptor (VEGFR-3) in glial reaction caused by human mesenchymal stem cell engraftment in normal rat brain. J Histochem Cytochem 015;63(3):170–80.Shin Y.J., Riew T.R., Park J.H., Lee M.Y. Expression of Vascular Endothelial Growth Factor-C (VEGF-C) and its receptor (VEGFR-3) in glial reaction caused by human mesenchymal stem cell engraftment in normal rat brain. J Histochem Cytochem 015;63(3):170–80.22.22. Xu Y., Zhong Y.J, Zhang W.Q, Song, J.H. Cooverexpression of matrix metalloproteinases-1 and vascular endothelial growth factor-C predicts poor prognosis in patients with glioma. Epidemiol 2013;37(5):697–702.Xu Y., Zhong Y.J, Zhang W.Q, Song, J.H. Cooverexpression of matrix metalloproteinases-1 and vascular endothelial growth factor-C predicts poor prognosis in patients with glioma. Epidemiol 2013;37(5):697–702.23.23. Grau S., Thorsteinsdottir J., von Baumgarten L. et al. Bevatsizumab May cause reactivity to VEGF-C and -D in the human brain and tumor derived endothelial cells. J Neurooncol 2011;104(1): 103–12.Grau S., Thorsteinsdottir J., von Baumgarten L. et al. Bevatsizumab May cause reactivity to VEGF-C and -D in the human brain and tumor derived endothelial cells. J Neurooncol 2011;104(1): 103–12.24.24. Shin Y.J., Choi J.S., Lee J.Y. et al. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 2008;116(5):517–27.Shin Y.J., Choi J.S., Lee J.Y. et al. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 2008;116(5):517–27.